Literature DB >> 16175175

TRIM family proteins: retroviral restriction and antiviral defence.

Sébastien Nisole1, Jonathan P Stoye, Ali Saïb.   

Abstract

Members of the tripartite motif (TRIM) protein family are involved in various cellular processes, including cell proliferation, differentiation, development, oncogenesis and apoptosis. Some TRIM proteins display antiviral properties, targeting retroviruses in particular. The potential activity of TRIM19, better known as promyelocytic leukaemia protein, against several viruses has been well documented and, recently, TRIM5alpha has been identified as the factor responsible for the previously described Lv1 and Ref1 antiretroviral activities. There is also evidence indicating that other TRIM proteins can influence viral replication. These findings are reviewed here, and the possibility that TRIMs represent a new and widespread class of antiviral proteins involved in innate immunity is also considered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175175     DOI: 10.1038/nrmicro1248

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  326 in total

1.  TRIM67 protein negatively regulates Ras activity through degradation of 80K-H and induces neuritogenesis.

Authors:  Hiroaki Yaguchi; Fumihiko Okumura; Hidehisa Takahashi; Takahiro Kano; Hiroyuki Kameda; Motokazu Uchigashima; Shinya Tanaka; Masahiko Watanabe; Hidenao Sasaki; Shigetsugu Hatakeyama
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

2.  Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7.

Authors:  Qiming Liang; Hongying Deng; Xiaojuan Li; Xianfang Wu; Qiyi Tang; Tsung-Hsien Chang; Hongzhuang Peng; Frank J Rauscher; Keiko Ozato; Fanxiu Zhu
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

3.  TRIM25 has a dual function in the p53/Mdm2 circuit.

Authors:  P Zhang; S Elabd; S Hammer; V Solozobova; H Yan; F Bartel; S Inoue; T Henrich; J Wittbrodt; F Loosli; G Davidson; C Blattner
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

4.  Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100.

Authors:  Florian Full; Nina Reuter; Katrin Zielke; Thomas Stamminger; Armin Ensser
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 5.  Molecular evolution of the antiretroviral TRIM5 gene.

Authors:  Welkin E Johnson; Sara L Sawyer
Journal:  Immunogenetics       Date:  2009-02-24       Impact factor: 2.846

Review 6.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

7.  Trim14 overexpression causes the same transcriptional changes in mouse embryonic stem cells and human HEK293 cells.

Authors:  Valentina V Nenasheva; Galina V Kovaleva; Nella V Khaidarova; Ekaterina V Novosadova; Ekaterina S Manuilova; Stanislav A Antonov; Vyacheslav Z Tarantul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-03       Impact factor: 2.416

8.  Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Neelam Dhiman; Megan M O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

9.  Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.

Authors:  Naomi Tsurutani; Jiro Yasuda; Naoki Yamamoto; Byung-Il Choi; Motohiko Kadoki; Yoichiro Iwakura
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  An expanded clade of rodent Trim5 genes.

Authors:  Semih U Tareen; Sara L Sawyer; Harmit S Malik; Michael Emerman
Journal:  Virology       Date:  2009-01-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.